bioRxivCancer BiologyPreprint
STING Promotes Breast Cancer Cell Survival by an Inflammatory-Independent Nuclear Pathway Enhancing the DNA Damage Response
Laura Cheradame, Ida C Guerrera, Julie Gaston, Alain Schmitt, Vincent Jung, Marion Pouillard, Nina Radosevic-Robin, Mauro Modesti, Jean-Gabriel Judde, Stefano Cairo, Vincent Goffin
Abstract
STING (Stimulator of Interferon Genes) is a well-known endoplasmic reticulum-anchored adaptor of the innate immunity that triggers the expression of inflammatory cytokines in response to pathogen infection. In cancer cells, this pro-inflammatory pathway can be activated by genomic DNA damage potentiating antitumor immune responses. Here we report that STING promotes cancer cell survival and resistance to genotoxic treatment in a cell-autonomous manner. Mechanistically, we show that STING partly localizes at the inner nuclear membrane in various breast cancer cell lines and clinical tumor samples, and interacts with several proteins of the DNA damage response (DDR). STING overexpression enhances the amount of chromatin-bound DNA-dependent Protein Kinase (DNA-PK) complex, while STING silencing impairs DDR foci formation and DNA repair efficacy. Importantly, this function of STING is independent of its canonical pro-inflammatory pathway. This study highlights a previously unappreciated cell-autonomous tumor-promoting mechanism of STING that opposes its well-documented role in tumor immunosurveillance. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=147 SRC="FIGDIR/small/196790v1_ufig1.gif" ALT="Figure 1"> View larger version (20K): org.highwire.dtl.DTLVardef@ba73f5org.highwire.dtl.DTLVardef@11319ccorg.highwire.dtl.DTLVardef@102bb4corg.highwire.dtl.DTLVardef@56b8a5_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: DNA methylation
- assay: proteomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Interferon-independent STING enforces epithelial genome-integrity checkpoint to restrain tumor evolution
Xiang Hang, Martina Macino, … Konrad Aden·bioRxiv·Mar 25, 2026
- The clinical and molecular significance associated with STING signaling in estrogen receptor-positive early breast cancer
E. E. Parkes, M. P. Humphries, … N. E. Buckley·bioRxiv·Jul 23, 2020
- Cancer cell-autonomous cGAS-STING response confers drug resistance
Q.-M. Lv, S.-Y. Wang, … L. Zhu·bioRxiv·Oct 23, 2021
- STING Licensing of Type I Dendritic Cells Potentiates Antitumor Immunity
- Innate immunity mediator STING modulates nascent DNA metabolism at stalled forks in human cells
Vy N. Nguyen, Salomé Brunon, … Julia M. Sidorova·bioRxiv·Apr 16, 2021
- Circulating Cell-Free Chromatin Particles Trigger a Unique Biphasic STING Signaling Program that Drives DNA Damage and Inflammation
Snehal Shabrish, Swamini Patade, … Indraneel Mittra·bioRxiv·Jul 31, 2026